Get started
MERCK & COMERCK & COMERCK & CO

MERCK & CO

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

1MRKX trade ideas

Merck: Water slide 🛝The pool-season is about to start, and Merck has already secured its place on the water slide, which should take it further downwards below the support at $110.66. However, there is still a 35% chance that the share might catch a bubbling fountain which could push it above the resistance at $119.65. In that case, we would expect Merck to develop a new top in the form of wave alt.B in green in the green zone between $119.87 and $123.79 first before turning downwards again.
NYSE:MRK
by MarketIntel
MRK - Rising Trend Channel [MID TERM]- MRK is in a rising trend channel in the medium long term. - The price has risen strongly since the positive signal from the rectangle formation at the break through resistance at 95.58. - The stock has broken up through resistance at 115. - Volume tops and volume bottoms correspond badly with tops and bottoms in the price. - The short term momentum of the stock is strongly positive, with RSI above 70. - This indicates increasing optimism among investors and further price increase for MRK. However, particularly for big stocks, high RSI may be a sign that the stock is overbought and that there is a chance of a reaction downwards. - Overall assessed as technically positive for the medium long term. *EP: Enter Price, SL: Support, TP: Take Profit, CL: Cut Loss, TF: Time Frame, RST: Resistance, RTS: Resistance to be Support LT TP: Long Term Target Price *Chart Pattern: DT - Double Top | BEARISH | RED DB - Double Bottom | BULLISH | GREEN HNS - Head & Shoulder | BEARISH | RED REC - Rectangle | BLUE iHNS - inverse head & Shoulder | BULLISH | GREEN Verify it first and believe later. WavePoint ❤️
NYSE:MRKLong
by wavepoint99
$MRK UndervaluedHigh Quality and Undervalued NYSE:MRK These eight indicators are all Bullish. If you owned NYSE:MRK for the last 5 years, then you have doubled your investment. There is no guarantee of the future but it looks like the near future target price is $121 Earnings Date: 27th April 2023 On-balance volume (OBV): Bullish Accumulation/distribution line: Bullish Average directional index (ADX): Bullish Aroon oscillator: Bullish Moving average convergence divergence (MACD): Bullish Relative strength index (RSI): Bullish Stochastic oscillator: Bullish Trend based on moving average crossover strategy: Bullish
NYSE:MRK
by VIN786
Merck Could Be Breaking OutMerck surged in late 2022 and consolidated during the first quarter. Now the drug maker could be breaking out. The first pattern on today’s chart is the rally between mid-October and early January, which included a breakout to new record highs. MRK then pulled back and retraced almost exactly half the move by early February. It bounced a little before making a slightly higher monthly low in late March. Second, MACD was rising in October before the previous surge. Notice how it’s climbing in a similar way now. Next is the 100-day simple moving average (SMA). The stock rallied from it in October -- also resembling the current price action. Finally, in the shorter term you have the March 7 high of $112.18. Consider how MRK briefly paused at that level in the last two weeks before proceeding to new record territory on Thursday. TradeStation has, for decades, advanced the trading industry, providing access to stocks, options, futures and cryptocurrencies. See our Overview for more. Important Information TradeStation Securities, Inc., TradeStation Crypto, Inc., and TradeStation Technologies, Inc. are each wholly owned subsidiaries of TradeStation Group, Inc., all operating, and providing products and services, under the TradeStation brand and trademark. TradeStation Crypto, Inc. offers to self-directed investors and traders cryptocurrency brokerage services. It is neither licensed with the SEC or the CFTC nor is it a Member of NFA. When applying for, or purchasing, accounts, subscriptions, products, and services, it is important that you know which company you will be dealing with. Please click here for further important information explaining what this means. This content is for informational and educational purposes only. This is not a recommendation regarding any investment or investment strategy. Any opinions expressed herein are those of the author and do not represent the views or opinions of TradeStation or any of its affiliates. Investing involves risks. Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options, futures, or digital assets); therefore, you should not invest or risk money that you cannot afford to lose. Before trading any asset class, first read the relevant risk disclosure statements on the Important Documents page, found here: www.tradestation.com .
NYSE:MRK
by TradeStation
(MRK) - Price Targets & Stop Loss 📈 What’s up investors! 📉 Welcome back to another one of 💡“Mike’s Ideas”.💡 I post as I find signals… these signals are based on the personal rules I have built and follow in order to make up what I call the “SST Strategy”. Follow for more ideas in the future!! I have 4 levels marked and colour coded on the Chart. These levels are: 🔴 Red = Stop Loss 🟢 Green = 1.2:1 Risk Reward Ratio 🟡 Yellow = 1.5:1 Risk Reward Ratio 🔵 Blue = 2:1 Risk Reward Ratio 👀 So what are we looking at today…!!! 🚨(MRK) Merck & Co., Inc.🚨 Operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
NYSE:MRKLong
by sststrategy
MRK | Time for Puts | MerckMerck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
NYSE:MRKShort
by DivergenceSeeker
1
TOP US-Stocks: Buy-Signal MRKThe stock just broke through a perfect buy point and triggered a buy-signal. The stop loss level and profit target are shown in the graphic. All stocks on our watchlists meet the hard selection criteria according to Mark Minervini's Trend-Template and William o' Neil's CAN SLIM methodology AND are in the process of developing a Perfect Buy Point and a low-risk entry, following a volatility contraction pattern. The stock just broke through a perfect buy point and triggered a buy-signal. The stop loss level and profit target are shown in the graphic. 🍾🍾 We trade like the Champions 🍾🍾 Are you struggling with your trading strategy? Follow me to get free, real-time trading signals which are all based on Mark Minervini's success-proven strategy.
NYSE:MRKLong
by JS_TechTrading
Merck has Potential. MRKDivergent on the downside across multiple timeframes. Betting on a triangle B formation, now due for a C Wave to the upside. No confirmation yet. Speculating that this might be a very short term event. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe.
NYSE:MRKLong
by Rykin_Capital